Efficacy of Oxymetazoline on Clinical Symptoms and Cilia Function Following Radiofrequency Turbinate Reduction: A randomized controlled trial

/A0 个研究点目标入组 52 人开始时间: 2023年3月21日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•The patients 18-year-old or older with chronic rhinitis either allergic rhinitis or non-allergic rhinitis who have failed at least 12-week medication therapy to control nasal obstructive symptom and have standard indication to go on radiofrequency for the turbinate reduction procedure.

•The exclusion criteria include previous turbinate surgery, severe septal deviation and significant septal spur which the septoplasty is considered the concurrent treatment, evidence of rhinosinusitis on clinical history or endoscopy or radiology, nasal valve disorder and autoimmune, infectious or neoplasms diseases such as Wegener disease, cystic fibrosis and lymphoma. The patients who had contraindication for topical decongestant use included cardiovascular diseases, glaucoma, hyperthyroidism, BPH and patients who had depression and were taking an MAOI antidepressant or patients who had history of previous rebound rhinitis.

发起方